Davis Polk advised InSilico Medicine in the transaction.InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million. The…
InSilico Medicine’s $35 Million Series D2 Financing


Davis Polk advised InSilico Medicine in the transaction.InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million. The…
…